Analytical Data
-
Gene name
Eef1akmt2
- Application
-
Alternative Names
EEF1A lysine methyltransferase 2(EC 2.1.1.-)(Methyltransferase-like protein 10)(Protein-lysine N-methyltransferase Mettl10)
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9D853
-
Expression Region
1-244aa
-
Molecular Weight
32.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Eef1akmt2, also known as Eukaryotic Translation Elongation Factor 1 Alpha Kinase 2, is a gene that encodes a protein involved in the regulation of protein synthesis. It is a member of the EEF1A family and plays a critical role in the translation process by modifying elongation factors, which are essential for the accurate and efficient synthesis of proteins. Recent studies have highlighted Eef1akmt2's potential involvement in various cellular processes, including stress response and cell proliferation. Additionally, the dysregulation of its expression has been linked to several diseases, particularly cancers, where altered protein synthesis is a hallmark. This has prompted researchers to investigate the functional properties and regulatory mechanisms of Eef1akmt2 through recombinant protein techniques. Generating recombinant Eef1akmt2 allows for detailed exploration of its structure-function relationship, interaction with other cellular components, and its role in translational control. Understanding these aspects is crucial for developing targeted therapies that could modulate its activity in pathological conditions. Therefore, Eef1akmt2 has emerged as a significant focal point in molecular biology and cancer research, encouraging further studies to elucidate its potential as a therapeutic target.
